This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Chlamydia pneumoniae is an intracellular bacterium that causes respiratory tract infection. AIM AND OBJECTIVE: The objective of the study was to evaluate the association between past C. pneumoniae infection and asthma. MATERIALS AND METHODS: We examined the presence of C. pneumoniae Immunoglobulin (IgG) and Immunoglobulin E (IgE) antibodies by the commercial quantitative Enzyme-linked immunosorbent assay kits in 87 asthmatic children and 87 controls. RESULTS: C. pneumoniae IgG antibody was significantly increased in patients (24.89 ± 16.65) as compared with controls (10.93 ± 6.75) P < 0.001. Further, the C. pneumoniae IgE antibody was significantly increased in patients (8.037 ± 4.645) compared to controls (6.52 ± 3.062) P = 0.024. There was a highly significant positive correlation between IgG and IgE levels ( P < 0.001* r = 0.466). There was no significant difference in C. pneumoniae IgG and C. pneumoniae IgE levels among asthma severity groups ( P = 0.507 and P = 0.539, respectively) and asthma-controlled groups ( P = 0.858 and P = 0.517, respectively). CONCLUSION: Compared to a control group, children with asthma have a significantly higher rate of C. pneumoniae IgG and C. pneumoniae IgE levels. In asthmatic patients, there is a positive correlation between C. pneumoniae IgG and C. pneumonia IgE. Controversially, C. pneumoniae infection has no role in asthma severity and control.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hameed et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: